American Portfolios Advisors Gt Biopharma, Inc. Call Options Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GTBP
# of Institutions
4Shares Held
564Call Options Held
0Put Options Held
0About GT Biopharma, Inc.
- Ticker GTBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,557,700
- Market Cap $96.4M
- Description
- GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...